Recent Updates — CI
On September 30, 2026, The Cigna Group hosted its Investor Day and reaffirmed its full-year 2026 financial outlook. The company projects consolidated adjusted revenues of approximately $280 billion and adjusted earnings per share of at least $30.45. Segment guidance includes Evernorth Health Services adjusted income from operations of at least $6.9 billion and Cigna Healthcare adjusted income from operations of at least $4.55 billion, with a medical care ratio target of 83.7% to 84.7%. Management also introduced a long-term adjusted EPS growth target of 10-14% annually through 2030 and announced a $3 billion multi-year modernization initiative. The Cigna Group operates in the global health insurance and services industry, providing healthcare coverage and pharmacy benefit management.
The Cigna Group reported second quarter 2026 financial results on July 30, 2026. Total revenues increased 7% to $71.7 billion compared to the prior year period. Shareholders' net income was $1.7 billion, or $6.29 per share, up from $1.5 billion, or $5.71 per share, in Q2 2025. Adjusted income from operations rose 6% to $2.1 billion, or $7.78 per share. The company raised its full-year 2026 outlook for adjusted income from operations to at least $30.45 per share, an increase of $0.10 from previous guidance. Additionally, Cigna Healthcare reported a medical care ratio of 84.5% and noted favorable prior year reserve development of $268 million for the first half of 2026. The company operates in the global health insurance and services industry.
The Cigna Group expects to reaffirm its full-year 2026 consolidated adjusted income from operations guidance of at least $30.35 per share during upcoming meetings with investors and analysts. This affirmation maintains the company's previous outlook communicated in late April 2026.
The Cigna Group issued a press release on April 30, 2026, announcing its financial results for the three months ended March 31, 2026. No specific financial figures were included in the text of this filing.
The Cigna Group held its Annual Meeting of Shareholders on April 22, 2026, where shareholders elected twelve directors and approved executive compensation and the appointment of PricewaterhouseCoopers LLP. A shareholder proposal regarding the right to act by written consent was defeated, receiving 104,982,574 votes in favor and 114,173,793 votes against.
The Cigna Group announced that Brian C. Evanko will succeed David M. Cordani as CEO effective July 1, 2026, at which time Cordani will transition to Executive Chair. The company also reaffirmed its 2026 financial guidance, projecting consolidated adjusted income from operations of at least $30.25 per share, Evernorth pre-tax adjusted income of at least $6.9 billion, and Cigna Healthcare pre-tax adjusted income of at least $4.5 billion.